N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine

C45H37F3N14 — CID 90702538

IUPACN-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
SMILESCC1=NC(c2ccccc2)=N/C1=N\c1c(C)nn2c(-c3cccc(C)c3)nn(C)c12.Cc1nn2c(C(F)(F)F)nn(C)c2c1/N=C1\N=C(c2ccccc2)N=C1c1ccccc1
InChIInChI=1S/C23H21N7.C22H16F3N7/c1-14-9-8-12-18(13-14)22-28-29(4)23-19(15(2)27-30(22)23)25-20-16(3)24-21(26-20)17-10-6-5-7-11-17;1-13-16(20-31(2)30-21(22(23,24)25)32(20)29-13)26-19-17(14-9-5-3-6-10-14)27-18(28-19)15-11-7-4-8-12-15/h5-13H,1-4H3;3-12H,1-2H3/b25-20-;26-19-
InChIKeyWXNQZNCUZJFRRI-BWXRLPDFSA-N
MW830.88 g/mol
LogP8.68
Rot. Bonds6

About N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine

N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine (PubChem CID 90702538) has the molecular formula C45H37F3N14 and a molecular weight of 830.88 g/mol. Its IUPAC name is N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine.

Molecular Properties

Compound NameN-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
PubChem CID90702538
Molecular FormulaC45H37F3N14
Molecular Weight830.88 g/mol
Exact Mass830.33
IUPAC NameN-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine
SMILESCC1=NC(c2ccccc2)=N/C1=N\c1c(C)nn2c(-c3cccc(C)c3)nn(C)c12.Cc1nn2c(C(F)(F)F)nn(C)c2c1/N=C1\N=C(c2ccccc2)N=C1c1ccccc1
InChIInChI=1S/C23H21N7.C22H16F3N7/c1-14-9-8-12-18(13-14)22-28-29(4)23-19(15(2)27-30(22)23)25-20-16(3)24-21(26-20)17-10-6-5-7-11-17;1-13-16(20-31(2)30-21(22(23,24)25)32(20)29-13)26-19-17(14-9-5-3-6-10-14)27-18(28-19)15-11-7-4-8-12-15/h5-13H,1-4H3;3-12H,1-2H3/b25-20-;26-19-
InChIKeyWXNQZNCUZJFRRI-BWXRLPDFSA-N
XLogP8.68
TPSA144.40 Ų
H-Bond Donors
H-Bond Acceptors12
Rotatable Bonds6
Heavy Atoms62
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500830.88
LogP ≤ 58.68
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
The IUPAC name of N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine (CID 90702538) is N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine.
What is the SMILES notation for N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
The canonical SMILES for N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine is CC1=NC(c2ccccc2)=N/C1=N\c1c(C)nn2c(-c3cccc(C)c3)nn(C)c12.Cc1nn2c(C(F)(F)F)nn(C)c2c1/N=C1\N=C(c2ccccc2)N=C1c1ccccc1.
What is the InChIKey of N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
The InChIKey is WXNQZNCUZJFRRI-BWXRLPDFSA-N. The full InChI is InChI=1S/C23H21N7.C22H16F3N7/c1-14-9-8-12-18(13-14)22-28-29(4)23-19(15(2)27-30(22)23)25-20-16(3)24-21(26-20)17-10-6-5-7-11-17;1-13-16(20-31(2)30-21(22(23,24)25)32(20)29-13)26-19-17(14-9-5-3-6-10-14)27-18(28-19)15-11-7-4-8-12-15/h5-13H,1-4H3;3-12H,1-2H3/b25-20-;26-19-.
What are the key properties of N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine?
N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine has a molecular weight of 830.88 g/mol, XLogP of 8.68, 6 rotatable bonds, 0 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1,6-dimethyl-3-(3-methylphenyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-5-methyl-2-phenylimidazol-4-imine;N-[1,6-dimethyl-3-(trifluoromethyl)pyrazolo[5,1-c][1,2,4]triazol-7-yl]-2,5-diphenylimidazol-4-imine is sourced from PubChem (CID 90702538), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).